Skip to main content
Top
Published in: HAND 3/2008

01-09-2008 | Report

Botulinum Toxin Use as an Adjunctive Modality in a Patient with Multiple Flexor Tendon Ruptures

Authors: Wade D. Kubat, Mark Rekant

Published in: HAND | Issue 3/2008

Login to get access

Abstract

Botulinum toxin A has been described in treatment protocols for several disease processes, from primary axillary hyperhydorosis to esophageal dysfunction. It is best known for its use in plastic and dermatological practices. Botulinum toxin has a straightforward mechanism of action. The toxin inhibits acetylcholine release at the neuromuscular junction causing a chemical denervation, which ceases contractions of the muscle. With its minimal side effect profile, botulinum toxin should be considered when muscle spasm is a detriment. This case involves an injury to the hand of a patient with a history of intermittent diffuse muscle spasms. Subsequently, due to the patient’s previous upper extremity muscle spasms, repeated flexor tendon repair ruptures of the index finger occurred until botulinum toxin was administered to the offending muscle. The patient has not required any additional surgical interventions for the repaired tendon and is now actively flexing all digits. This case report demonstrates how botulinum toxin can be used in a clinical scenario when decreased muscle activity is desired to promote tendon healing.
Literature
1.
go back to reference Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. N Engl J Med 2002;347(6):395–400.PubMedCrossRef Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. N Engl J Med 2002;347(6):395–400.PubMedCrossRef
2.
go back to reference Corry IS, Cosgrove AP, Walsh EG, et al. Botulinum toxin A in the hemiplegic limb: a double-blind trial. Dev Med Child Neurol 1997;39:185–93.PubMedCrossRef Corry IS, Cosgrove AP, Walsh EG, et al. Botulinum toxin A in the hemiplegic limb: a double-blind trial. Dev Med Child Neurol 1997;39:185–93.PubMedCrossRef
3.
go back to reference Frei K, Truong DD, Dressler D. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol 2006;13(Suppl 1):30–5.PubMedCrossRef Frei K, Truong DD, Dressler D. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol 2006;13(Suppl 1):30–5.PubMedCrossRef
4.
go back to reference Koman LA, Paterson Smith B, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs 2003;5:11–23.PubMed Koman LA, Paterson Smith B, Balkrishnan R. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Paediatr Drugs 2003;5:11–23.PubMed
5.
go back to reference Rodriquez A, McGinn M, Chappell R. Botulinum toxin injection of spastic finger flexors in hemiplegic patients. Am J Phys Med Rehabil 2000;79(1):44–7.PubMedCrossRef Rodriquez A, McGinn M, Chappell R. Botulinum toxin injection of spastic finger flexors in hemiplegic patients. Am J Phys Med Rehabil 2000;79(1):44–7.PubMedCrossRef
6.
go back to reference Tuzuner S, Balci N, Ozkaynak S. Results of zone II flexor tendon repair in children younger than age 6 Years: botulinum toxin type A administration eased cooperation during the rehabilitation and improved outcome. J Pediatr Orthop 2004;24(6):629–33.PubMed Tuzuner S, Balci N, Ozkaynak S. Results of zone II flexor tendon repair in children younger than age 6 Years: botulinum toxin type A administration eased cooperation during the rehabilitation and improved outcome. J Pediatr Orthop 2004;24(6):629–33.PubMed
7.
go back to reference Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type A and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial. Arch Phys Med Rehabil 2007;88:1–10.PubMedCrossRef Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type A and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial. Arch Phys Med Rehabil 2007;88:1–10.PubMedCrossRef
Metadata
Title
Botulinum Toxin Use as an Adjunctive Modality in a Patient with Multiple Flexor Tendon Ruptures
Authors
Wade D. Kubat
Mark Rekant
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
HAND / Issue 3/2008
Print ISSN: 1558-9447
Electronic ISSN: 1558-9455
DOI
https://doi.org/10.1007/s11552-008-9091-5

Other articles of this Issue 3/2008

HAND 3/2008 Go to the issue